Beyond the closed suture in apert syndrome mouse models: Evidence of primary effects of FGFR2 signaling on facial shape at birth

Developmental Dynamics

Volumn 239, Issue 11, 2010, Pages 3058-3071

  Martínez Abadías, Neus ^a   Percival, Christopher ^a   Aldridge, Kristina ^b   Hill, Cheryl A ^b   Ryan, Timothy ^a   Sirivunnabood, Satama ^a   Wang, Yingli ^c   Jabs, Ethylin Wang ^c   Richtsmeier, Joan T ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b University of Missouri   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apert syndrome; Craniofacial shape; Craniosynostosis; FGFR2; Mouse model; Suture

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2;

ACROCEPHALOSYNDACTYLY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; FACE; FACE DEVELOPMENT; GENETIC VARIABILITY; MOUSE; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ACROCEPHALOSYNDACTYLIA; ANIMALS; ANIMALS, NEWBORN; CRANIOSYNOSTOSES; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SKULL;

MUS; MUS MUSCULUS;

EID: 77958594664     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.22414     Document Type: Article

References (63)

1. Aldridge K, Boyadjiew S, Capone G, DeLeon V, Richtsmeier JT. 2005. Precision and error of three-dimensional phenotypic measures acquired from 3dMD photogrammetric images. Amer J Med Genet 138: 247-253.
2. Aldridge K, Hill CA, Austin JR, Percival C, Martinez-Abadias N, Neuberger T, Wang Y, Jabs EW, Richtsmeier JT. 2010. Brain phenotypes in two FGFR2 mouse models for Apert syndrome. Dev Dyn 239: 987-997.
3. Bachler M, Neubuser A. 2001. Expression of members of the Fgf family and their receptors during midfacial development. Mech Dev 100: 313-316.
4. Britto JA, Evans RD, Hayward RD, Jones BM. 2002. Toward pathogenesis of Apert cleft palate: FGF, FGFR, and TGF beta genes are differentially expressed in sequential stages of human palatal shelf fusion. Cleft Palate Craniofac J 39: 332-340.
5. Chen L, Li D, Li C, Engel A, Deng CX. 2003. A Ser252Trp [corrected] substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 33: 169-178.
6. Cheverud J. 1995. Morphological integration in the Saddle-Back Tamarin (Saguinus fuscicollis) cranium. Am Naturalist 145: 63-89.
7. Cohen MM, Jr. 1986. Craniosynostosis: diagnosis, evaluation, and management. New York: Raven Press.
8. Cohen M Jr. 2000. Apert syndrome. In: Cohen M Jr, MacLean R, editors. Craniosynostosis: diagnosis, evaluation, and management. New York: Oxford University Press. p 316-353.
9. Cohen MM Jr, MacLean R, editors. 2000. Craniosynostosis: diagnosis, evaluation, and management. New York: Oxford University Press.
10. Cohen MM Jr. 1993. Sutural biology and the correlates of craniosynostosis. Am J Med Genet 47: 581-616.
11. Cohen MM Jr, Kreiborg S. 1996. A clinical study of the craniofacial features in Apert syndrome. Int J Oral Maxillofac Surg 25: 45-53.
12. Cohen MM Jr, Kreiborg S, Lammer EJ, Cordero JF, Mastroiacovo P, Erickson JD, Roeper P, Martinez-Frias ML. 1992. Birth prevalence study of the Apert syndrome. Am J Med Genet 42: 655-659.
13. Cole T III. 2002. WinEDMA Version 1.0.1 beta. Windows-Based Software for Euclidean Distance Matrix Analysis.
14. Cunningham ML, Seto ML, Ratisoontorn C, Heike CL, Hing AV. 2007. Syndromic craniosynostosis: from history to hydrogen bonds. Orthod Craniofac Res 10: 67-81.
15. Drake AG, Klingenberg CP. 2008. The pace of morphological change: historical transformation of skull shape in St Bernard dogs. Proc Biol Sci 275: 71-76.
16. Dryden I, Mardia K. 1998. Statistical shape analysis. Chichester: John Wiley and Sons.
17. Du X, Weng T, Sun Q, Su N, Chen Z, Qi H, Jin M, Yin L, He Q, Chen L. 2010. Dynamic morphological changes in the skulls of mice mimicking human Apert syndrome resulting from gain-of-function mutation of FGFR2 (P253R). J Anat 217: 97-105.
18. Ford-Perriss M, Abud H, Murphy M. 2001. Fibroblast growth factors in the developing central nervous system. Clin Exp Pharmacol Physiol 28: 493-503.
19. Hajihosseini MK. 2008. Fibroblast growth factor signaling in cranial suture development and pathogenesis. In: Rice D, editor. Craniofacial sutures: development, disease and treatment. Front Oral Biol. Basel: Karger. p 160-177.
20. Holmes G, Rothschild G, Roy UB, Deng CX, Mansukhani A, Basilico C. 2009. Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology. Dev Biol 328: 273-284.
21. Ibrahimi OA, Eliseenkova AV, Plotnikov AN, Yu K, Ornitz DM, Mohammadi M. 2001. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci USA 98: 7182-7187.
22. Inatani M, Irie F, Plump AS, Tessier-Lavigne M, Yamaguchi Y. 2003. Mammalian brain morphogenesis and midline axon guidance require heparan sulfate. Science 302: 1044-1046.
23. Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM. 2002. Tissue origins and interactions in the mammalian skull vault. Dev Biol 241: 106-116.
24. Klingenberg C. 2008. MorphoJ. In: Faculty of Life Sciences, University of Manchester, UK:
25. Lajeunie E, Cameron R, El Ghouzzi V, de Parseval N, Journeau P, Gonzales M, Delezoide AL, Bonaventure J, Le Merrer M, Renier D. 1999. Clinical variability in patients with Apert's syndrome. J Neurosurg 90: 443-447.
26. Lele S, Richtsmeier J. 1995. Euclidean distance matrix analysis: confidence intervals for form and growth differences. Am J Phys Anthropol 98: 73-86.
27. Lele S, Richtsmeier JT. 2001. An invariant approach to the statistical analysis of shapes. London: Chapman and Hall/CRC Press. 308 p.
28. Marie PJ, Kaabeche K, Guenou H. 2008. Roles of FGFR2 and Twist in human craniosynostosis: insights from genetic mutations in cranial osteoblasts In: Rice D, editor. Craniofacial sutures. development, disease and treatment. Front Oral Biol. Basel: Karger. p 144-159.
29. Merrill AE, Bochukova EG, Brugger SM, Ishii M, Pilz DT, Wall SA, Lyons KM, Wilkie AO, Maxson RE Jr. 2006. Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis. Hum Mol Genet 15: 1319-1328.
30. Nie X, Luukko K, Kettunen P. 2006. FGF signalling in craniofacial development and developmental disorders. Oral Dis 12: 102-111.
31. Opperman L. 2000. Cranial sutures as intramembranous bone growth sites. Dev Dyn 219: 472-485.
32. Ornitz DM, Itoh N. 2001. Fibroblast growth factors. Genome Biol 2: 1-12.
33. Ornitz DM, Marie PJ. 2002. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16: 1446-1465.
34. Park W, Meyers G, Li X, Theda C, Day D, SJ Orlow, Jones M, Jabs E. 1995a. Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum Mol Genet 4: 1229-1233.
35. Park WJ, Theda C, Maestri NE, Meyers GA, Fryburg JS, Dufresne C, Cohen MM Jr, Jabs EW. 1995b. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am J Hum Genet 57: 321-328.
36. Plotnikov AN, Hubbard SR, Schlessinger J, Mohammadi M. 2000. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 101: 413-424.
37. Quarto N, Wan DC, Kwan MD, Panetta NJ, Li S, Longaker MT. 2010. Origin Matters: Differences in Embryonic Tissue Origin and Wnt Signaling Determine the Osteogenic Potential and Healing Capacity of Frontal and Parietal Calvarial Bones. J Bone Miner Res 25: 1680-1694.
38. Reyment R, Blackith R, Campbell N. 1984. Multivariate morphometrics. London: Academic Press. 233 p.
39. Rice D. 2008. Developmental anatomy of craniofacial sutures. In: Rice D, editor. Craniofacial sutures: development, disease and treatment. Front Oral Biol. Basel: Karger. p 1-21.
40. Rice R, Spencer-Dene B, Connor EC, Gritli-Linde A, McMahon AP, Dickson C, Thesleff I, Rice DP. 2004. Disruption of Fgf10/Fgfr2b-coordinated epithelial-mesenchymal interactions causes cleft palate. J Clin Invest 113: 1692-1700.
41. Richtsmeier JT. 2002. Cranial vault morphology and growth in craniosynostoses. In: Mooney MP, Siegel MI, editors. Understanding craniofacial anomalies: the etiopathogenesis of craniosynostoses and facial clefting. New York: Wiley-Liss. p 321-341.
42. Richtsmeier JT, Lele S. 1993. A coordinate-free approach to the analysis of growth patterns: models and theoretical considerations. Biol Rev Camb Phil Soc 68: 381-411.
43. Richtsmeier J, Paik C, Elfert P, Cole TI, Dahlman H. 1995. Precision, repeatability, and validation of the localization of cranial landmarks using computed tomography scans. Cleft Palate Craniofac J 32: 217-227.
44. Rohlf FJ, Slice D. 1990. Extensions of the Procrustes method for the optimal superimposition of landmarks. Syst Zool 39: 40-59.
45. Roybal PG, Wu NL, Sun J, Ting MC, Schafer CA, Maxson RE. 2010. Inactivation of Msx1 and Msx2 in neural crest reveals an unexpected role in suppressing heterotopic bone formation in the head. Dev Biol 343: 28-39.
46. Schuller AC, Ahmed Z, Ladbury JE. 2008. Extracellular point mutations in FGFR2 result in elevated ERK1/2 activation and perturbation of neuronal differentiation. Biochem J 410: 205-211.
47. Slaney SF, Oldridge M, Hurst JA, Moriss-Kay GM, Hall CM, Poole MD, Wilkie AO. 1996. Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. Am J Hum Genet 58: 923-932.
48. Snyder-Warwick AK, Perlyn CA, Pan J, Yu K, Zhang L, Ornitz DM. 2010. Analysis of a gain-of-function FGFR2 Crouzon mutation provides evidence of loss of function activity in the etiology of cleft palate. Proc Natl Acad Sci USA 107: 2515-2520.
49. nd ed. Shelton, CT: People's Medical Publishing House.
50. Szabo-Rogers HL, Geetha-Loganathan P, Nimmagadda S, Fu KK, Richman JM. 2008. FGF signals from the nasal pit are necessary for normal facial morphogenesis. Dev Biol 318: 289-302.
51. Ting MC, Wu NL, Roybal PG, Sun J, Liu L, Yen Y, Maxson RE Jr. 2009. EphA4 as an effector of Twist1 in the guidance of osteogenic precursor cells during calvarial bone growth and in craniosynostosis. Development 136: 855-864.
52. Turner N, Grose R. 2010. Fibroblast growth factor signaling: from development to cancer. Nat Rev Cancer 10: 116-129.
53. Twigg SR, Healy C, Babbs C, Sharpe JA, Wood WG, Sharpe PT, Morriss-Kay GM, Wilkie AO. 2009. Skeletal analysis of the Fgfr3(P244R) mouse, a genetic model for the Muenke craniosynostosis syndrome. Dev Dyn 238: 331-342.
54. von Gernet S, Golla A, Ehrenfels Y, Schuffenhauer S, Fairley JD. 2000. Genotype-phenotype analysis in Apert syndrome suggests opposite effects of the two recurrent mutations on syndactyly and outcome of craniofacial surgery. Clin Genet 57: 137-139.
55. Wang Y, Xiao R, Yang F, Karim BO, Iacovelli AJ, Cai J, Lerner CP, Richtsmeier JT, Leszl JM, Hill CA, Yu K, Ornitz DM, Elisseeff J, Huso DL, Jabs EW. 2005. Abnormalities in cartilage and bone development in the Apert syndrome FGFR2 (+/S252W) mouse. Development 132: 3537-3548.
56. Wang Y, Sun M, Uhlhorn VL, Zhou X, Peter I, Martinez-Abadias N, Hill CA, Percival CJ, Richtsmeier JT, Huso DL, Jabs EW. 2010. Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2+P253R mice. BMC Dev Biol 10: 22.
57. Weiss K, Buchanan A. 2004. Genetics and the logic of evolution. New York: Wiley-Liss. 541 p.
58. Weiss KM. 2005. The phenogenetic logic of life. Nat Rev Genet 6: 36-45.
59. Wilke TA, Gubbels S, Schwartz J, Richman JM. 1997. Expression of fibroblast growth factor receptors (FGFR1, FGFR2, FGFR3) in the developing head and face. Dev Dyn 210: 41-52.
60. Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, Rutland P, Malcolm S, Winter RM, Reardon W. 1995. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9: 165-172.
61. Yu K, Ornitz DM. 2001. Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes. Proc Natl Acad Sci USA 98: 3641-3643.
62. Yu K, Herr AB, Waksman G, Ornitz DM. 2000. Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc Natl Acad Sci USA 97: 14536-14541.
63. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, Towler DA, Ornitz DM. 2003. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130: 3063-3074.